Analysis of seven selected cannabinoids in human plasma highlighting matrix and solution stability assessments
Journal of Analytical Toxicology · 2025
DOI: 10.1093/jat/bkaf087 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Journal of Analytical Toxicology, 2025. Verfasst von David J Anderson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Human Toxicology and Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112, United States. Hauptthemen laut MEDLINE: Cannabinoids, Substance Abuse Detection. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDA NIH HHS, ALSAM Foundation, National Institute on Drug Abuse.
Abstract (Originalsprache)
Cannabis consumption has and continues to increase dramatically, as does its legalization for recreational and/or medicinal use at the state, but not at the federal level. The increased consumption and legalization have spurred significant cannabis focused research, with particular interest in defining the pharmacokinetic characteristics of this complex natural product. Supporting this research requires a bioanalytical method that accurately and simultaneously quantifies the primary cannabinoids and their metabolites. The objective of this method validation was to meet pre-specified sensitivity targets (0.5 ng/mL for most analytes) from a low sample volume (0.2 mL) and a single extraction approach that could quantify Δ9-tetrahydrocannabinol, cannabidiol, and their metabolites. Moreover, we sought to rigorously characterize the stability of included cannabinoid analytes, both in solution and plasma. The developed assay required optimization of extraction and mobile phase solvents, as well as mass transitions to achieve the selectivity required to meet the desired sensitivity targets. Stability experiments indicated solution stability of no more than 6 months when stored in polypropylene at −30 or −80°C and ∼3 years (34.5 months) of plasma stability when stored in polypropylene at −80°C. The assay was successfully applied to ∼1650 samples without a batch failure. This validated LC–MS/MS assay provides unique information on cannabinoid stability and has been utilized to generate novel data on the pharmacokinetics of cannabis constituents and their metabolites.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Center for Human Toxicology and Department of Pharmacology and Toxicology, University of Utah, Salt Lake City, UT 84112, United States.
ORCID-Profile: Joseph E Rower
Förderung
- NIDA NIH HHS
- ALSAM Foundation
- National Institute on Drug Abuse
Zitieren
APA
Anderson, D. J., Freeman, T. S., Caldwell, K. S., Hoggard, L. R., Reilly, C. A., & Rower, J. E. (2025). Analysis of seven selected cannabinoids in human plasma highlighting matrix and solution stability assessments. Journal of Analytical Toxicology. https://doi.org/10.1093/jat/bkaf087
Vancouver
Anderson DJ, Freeman TS, Caldwell KS, Hoggard LR, Reilly CA, Rower JE. Analysis of seven selected cannabinoids in human plasma highlighting matrix and solution stability assessments. Journal of Analytical Toxicology. 2025. doi:10.1093/jat/bkaf087
BibTeX
@article{Anderson2025,
author = {Anderson, David J and Freeman, Tia S and Caldwell, Kalii S and Hoggard, Logan R and Reilly, Christopher A and Rower, Joseph E},
title = {Analysis of seven selected cannabinoids in human plasma highlighting matrix and solution stability assessments},
journal = {Journal of Analytical Toxicology},
year = {2025},
doi = {10.1093/jat/bkaf087}
}
EUVIMED